1-4 of 4
Sandy Amorin
Close
Sort by
Journal Articles

Verlen, “Very Elderly Rituximab Associated to Lenalidomide - Tafasitamab Combination in Frontline DLBCL Patients”, a Phase II Open-Label Study Evaluating Efficacy of Lenalinomide and Tafasitamab Combination Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older from the Lysa Group

Benoit Tessoulin, Julien Depaus, Pierre Feugier, Ludovic Fouillet, Julie Abraham, Sandy Amorin, Fabrice Jardin, Franck Morschhauser, Catherine Thieblemont, François-Xavier Gros, Bertrand Joly, Hacene Zerazhi, Sophie Bernard, Adrien Chauchet, Stéphane Vigouroux, Christophe Bonnet, Sarah Bailly, Steven Le Gouill
Journal: Blood
Blood (2023) 142 (Supplement 1): 3094.
https://doi.org/10.1182/blood-2023-173265
Published: 2023
Journal Articles

Amahrelis : Adcetris Maintenance after Autologous Stem Cell Transplantation in Hodgkin Lymphoma : A Real Life Study from Sfgmtc and Lysa Groups

Amira Marouf, Anne Ségolène Cottereau, MD, Guillemette Fouquet, MD, Salim Kanoun, MD, Patricia Franchi, MD, Romain Ricci, Michel Meignan, MD, David Sibon, MD PhD, Thomas Gastinne, MD, Cecile Borel, MD, Mohammad Hammoud, MD, Guillaume Sicard, MD, Romane Gille, Doriane Cavalieri, MD, Aspasia Stamatoulas Bastard, MD, Lauriane Clement-Filliatre, MD, Julien Lazarovici, MD, Adrien Chauchet, MD, Luc Mathieu Fornecker, MD PhD, Sandy Amorin, MD, Mathieu Roquet, Nicole Raus, Data Manager, Rene-Olivier Casasnovas, MD, Guillaume Cartron, MD PhD, Hervé Ghesquieres, MD PhD, Pauline Brice, MD, Olivier Hermine, Didier Bouscary, MDPhD, Marie Thérèse Rubio, MD PhD, Jerome Tamburini, MD PhD, Benedicte Deau Fischer
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-138666
Published: 2020
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”

Remy Gressin, MD, Mary Callanan, MD, PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Guillaume Cartron, MD, PhD, Anne Schmitt, MD, Roch Houot, MD, PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD, PhD, Anne Banos, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD, PhD, Lionel Kardin, MD, Gandhi Damaj, MD, Pierre Feugier, MD, PhD, luc Matthieu Fornacker, MD, Cecile molucon Chabrot, MD, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Philippe Solal-Céligny, MD, Nadine Morineau, MD, Marie Pierre Moles, MD, Hacene Zerazhi, MD, Jean Fontan, MD, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 370.
https://doi.org/10.1182/blood.V122.21.370.370
Published: 2013